SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-102782
Filing Date
2017-03-30
Accepted
2017-03-30 07:22:02
Documents
3
Period of Report
2017-03-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d369565d8k.htm 8-K 13203
2 EX-99.1 d369565dex991.htm EX-99.1 67029
3 GRAPHIC g369565g0329092131254.jpg GRAPHIC 3631
  Complete submission text file 0001193125-17-102782.txt   86537
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36304 | Film No.: 17723746
SIC: 2834 Pharmaceutical Preparations